12
Mar
2015
Antibiotic R&D Is Getting More Attention. Who’s Doing What?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account. 
Share:
9
Mar
2015
2015 Power Rankings: Biotech Investment Banks
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
6
Mar
2015
Esperion Jockeys For Place Between Statins and the Next Big Class of Heart Drugs
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
3
Mar
2015
Come Celebrate at the Timmerman Report Launch Party
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Mar
2015
Margaret Hamburg: One of the Best Commissioners in FDA History
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
25
Feb
2015
The Tularik Alumni: Where Are They Now?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
23
Feb
2015
Who Is Poised To Go Public in 2015, and Who Isn’t?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
20
Feb
2015
Five Things to Watch at Next Week’s Big Genomics Show
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
19
Feb
2015
Global Blood Zeroes in on Sickle Cell, a Potentially Big, and Touchy, Opportunity
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
17
Feb
2015
Frazier, Versant Find an AFib Drug To Bet on at Laguna
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
13
Feb
2015
How’s It Going at the Biotech Journalism Startup? Much Better Than Expected
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
12
Feb
2015
Video: Alnylam’s John Maraganore and Canaan’s Julie Papanek at BIO CEO
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
11
Feb
2015
Intelligent MDx, Maker of Molecular Diagnostics That Raised $40M, Shuts Down
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
11
Feb
2015
FAQs About the Timmerman Report
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
9
Feb
2015
Cellular Dynamics Tracks Down ‘Superdonors’ for Cell Therapy
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
6
Feb
2015
Q&A: Affymetrix Founder Stephen Fodor Resurfaces at Cellular Research
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
5
Feb
2015
Former Dendreon CEO Lures Ex-Amgen Scientists to Immunotherapy Startup
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
4
Feb
2015
Seattle Genetics Commercial Boss Leaves for President Gig at Bristol-Myers
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
4
Feb
2015
Third Rock’s Obesity Hopeful, Ember Therapeutics, Closes Down
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Feb
2015
The Merck Exodus: Where Are the Talented People Going?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share: